Abstract
Pluripotent and multipotent cells become increasingly lineage restricted through differentiation. Alterations to the cellular proteoglycan composition and structure should accompany these changes to influence cell proliferation, delineation of tissues and acquisition of cell migration capabilities. Retinoic acid plays an important role in pre-patterning of the early embryo. Retinoic acid can be used in vitro to induce differentiation, causing pluripotent and multipotent cells to become increasingly lineage restricted. We examined retinoic acid-induced changes in the cellular proteoglycan composition of the well-characterized teratocarcinoma line NCCIT. Our analysis revealed changes in the abundance of transcripts for genes encoding core proteins, enzymes that are responsible for early and late linkage region biosynthesis, as well as enzymes for GAG chain extension and modification. Transcript levels for genes encoding core proteins used as backbones for polysaccharide synthesis revealed highly significant increases in expression of lumican and decorin, 1,500-fold and 2,800-fold, respectively. Similarly, glypican 3, glypican 5, versican and glypican 6 showed increases between 5 and 70-fold. Significant decreases in biglycan, serglycin, glypican 4, aggrecan, neurocan, CD74 and glypican 1 were observed. Disaccharide analysis of the glycans in heparin/heparan sulfate and chondroitin/dermatan sulfate revealed retinoic acid-induced changes restricted to chondroitin/dermatan sulfate glycans. Our study provides the first detailed analysis of changes in the glycosaminoglycan profile of human pluripotent cells upon treatment with the retinoic acid morphogen.
Similar content being viewed by others
Abbreviations
- Ac:
-
Acetyl
- BCA assay:
-
Bicinchoninic acid assay
- BEH:
-
Ethylene bridged hybrid
- C5Epi :
-
C5Epimerase
- cDNA:
-
Complementary deoxyribonucleic acid
- CHAPS:
-
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate
- CS/DS:
-
Chondroitin sulfate/dermatan sulfate
- ΔUA:
-
4-deoxy-α-L-threo-hex-4-enopryanosyluronic acid
- GAG:
-
Glycosaminoglycan
- GalN:
-
Galactosamine
- GFAP:
-
Glial fibrillary acid protein
- GlcA:
-
Glucuronic acid
- IdoA:
-
Iduronic acid
- GlcN:
-
Glucosamine
- HRP:
-
Horseradish peroxidase
- HFIP:
-
1,1,1,3,3,3-hexafluoro-2-propanol
- HP/HS:
-
Heparin/heparan sulfate
- HXA:
-
Hexylamine
- KRTAP3-2:
-
Keratin associated protein 3-2
- LC/MS:
-
Liquid chromatography/mass spectrometry
- NDST:
-
N-deacetylase-N-sulfotransferase
- PVDF:
-
Polyvinyl difluoride
- qRT-PCR:
-
Quantitative reverse transcription-polymerase chain reaction
- RA:
-
Retinoic acid
- RPS18:
-
Ribosomal protein S18
- RNA:
-
Ribonucleic acid
- S:
-
Sulfo
- TrBA:
-
Tributylamine
- UPLC:
-
Ultra-performance liquid chromatography
- WB:
-
Western immunoblotting
- HS2ST:
-
2-O-sulfotransferase
- HS3ST:
-
3-O-sulfotransferase
- HS6ST:
-
6-O-sulfotransferase
References
Davies, J.A., Fisher, C.E., et al.: Glycosaminoglycans in the study of mammalian organ development. Biochem. Soc. Trans. 29, 166–171 (2001)
Linhardt, R.J., Toida, T.: Role of glycosaminoglycans in cellular communication. Accts. Chem. Res. 37, 431–438 (2004)
Lanctot, P.M., Gage, F.H., et al.: The glycans of stem cells. Curr. Opin. Chem. Biol. 11, 373–380 (2007)
Andrews, P.W., Martin, M.M., et al.: Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem. Soc. Trans. 33, 1526–1530 (2005)
Damjanov, I.: Teratocarcinoma stem cells. Cancer Surv. 9, 303–319 (1990)
Pierce, G.B.: Carcinoma is to embryology as mutation is to genetics. Amer. Zool. 25, 707–712 (1985)
Teshima, S., Shimosato, Y., et al.: Four new human germ cell lines. Lab. Investig. 59, 328–336 (1988)
Damjanov, I., Horvat, B., et al.: Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT. Lab. Investig. 68, 220–232 (1993)
Esko, J.D.: Genetic analysis of proteoglycan structure, function and metabolism. Curr. Opin. Cell Biol. 3, 805–816 (1991)
Linhardt, R.J., Claude, S.: Hudson Award address in carbohydrate chemistry. Heparin: structure and activity. J. Medic. Chem. 46, 2551–2564 (2003)
Skidmore, M.A., Guimond, S.E., et al.: The activities of heparan sulfate and its analogue heparin are dictated by biosyntehsis, sequence and conformation. Connect. Tissue Res. 49, 140–144 (2008)
Sugahara, K., Kitagawa, H.: Heparin and heparan sulfate biosynthesis. JUBMB Life. 54, 163–175 (2002)
Packer, A.I., Mailutha, K.G., et al.: Regulation of the Hoxa4 and Hoxa5 genes in the embryonic mouse lung by retinoic acid and TGFβ1: implications for lung development and patterning. Dev. Dynam. 217, 62–74 (2000)
Lee, D.C.W., Chan, K.W., et al.: RET receptor typosine kinase isoforms in kidney function and disease. Oncogene 21, 5582–5592 (2002)
Kumar, S., Duester, G.: Retinoic acid signaling in perioptic mesenchyme represses Wnt signaling via induction of Pitx2 and Dkk2. Dev. Biol. 340, 67–74 (2010)
Dahlstrand, J., Zimmerman, L.B., et al.: Characterization of the human nestin gene reveals a close evolutionary relationship to neurofilaments. J. Cell Sci. 103, 589–597 (1992)
Couchman, J.R.: Transmembrane signaling proteoglycans. Annu. Rev. Cell. Dev. Biol. 26, 89–114 (2010)
Esko, J.D., Kimata, K., et al.: Essentials of Glycobiology. Cold Spring Harbor Laboratory Press, Cold Spring Harbor (2009)
Hanemann, C.O., Kuhn, G., et al.: Expression of decorin mRNA in the nervous system of rat. J. Histochem. Cytochem. 41, 1383–1391 (1993)
Minor, K., Tang, X., et al.: Decorin promotes robust axon growth on inhibitory CSPGs and myelin via a direct effect on neurons. Neurobiol. Dis. 32, 88–95 (2008)
Troup, S., Njue, C., et al.: Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin. Cancer Res. 9, 207–214 (2003)
Lemons, M.L., Barua, S., et al.: Adaptation of sensory neurons to hyalectin and decorin proteoglycans. J. Neurosci. 25, 4964–4973 (2005)
Weber, C.K., Sommer, G., et al.: Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology 121, 657–667 (2001)
Saunders, S., et al.: Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain. Dev. Biol. 190, 78–93 (1997)
Williamson, D., Selfe, S., et al.: Cancer Res. 67, 57 (2007)
Capurro, M.I., Shi, W., et al.: Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth. J. Biol. Chem. 280, 41201–41206 (2005)
Filmus, J.: Glypicans in growth control and cancer. Glycobiology 11, 19R–23R (2001)
Sung, Y.K., Hwang, S.Y., et al.: Glypican-3 is overexpressed in human hepatocellular carcinoma. Cancer Sci. 94, 259–262 (2005)
Lai, J.P., Sandhu, D.S., et al.: Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma. Hepatology 47, 1211–1222 (2008)
Bishop, J.R., Schuksz, M., et al.: Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446, 1030–1037 (2007)
Aikawa, J., Esko, J.D.: Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAcN-Deacetylase/ N-Sulfotransferase family. J. Biol. Chem. 274, 2690–2695 (1999)
Aikawa, J., Grobe, K., et al.: Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4. J. Biol. Chem. 276, 5876–5882 (2001)
Grobe, K., Ledin, J., et al.: Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes. Biochim. Biophys. Acta 1573, 209–215 (2002)
Kusche-Gullberg, M., Kjellén, L.: Sulfotransferases in glycosaminoglycan biosynthesis. Curr. Opin. Struc. Biol. 13, 605–611 (2003)
Filmus, J., Capurro, M.I., et al.: Glypicans. Genome Biol. 8, 224 (2008)
Kraushaar, D.C., Yamaguchi, Y., et al.: Heparan sulfate is required for embryonic stem cells to exit from self-renewal. J. Biol. Chem. 285, 5907–5916 (2010)
Funderburgh, J.L.: Keratan sulfate biosynthesis. IUBMB Life. 54, 187–194 (2002)
Funderburgh, J.L., Caterson, B., et al.: Keratan sulfate proteoglycan during embryonic development of the chicken cornea. Dev. Biol. 116, 267–277 (1986)
Brown, J.J., Papaioannou, V.E.: Ontogeny of hyaluronan secretion during early mouse development. Development 117, 483–492 (1993)
Toole, B.P.: Hyaluronan in morphogenesis. Sem. Cell. Dev. Biol. 12, 79–87 (2001)
Paluh, J.L., Dai, G., et al.: In search of the Holy Grail: engineering the stem cell niche. Eur. Pharm. Rev. 16, 28–33 (2011)
Li, B., Liu, H., et al.: Analysis of glycosaminoglycans in stem cell glycomics. Methods Mol. Biol. Humana Press 690, 285–300 (2011)
Nairn, A.V., Kinoshita-Toyoda, A., et al.: Glycomics of proteoglycan biosynthesis in murine embryonic stem cell differentiation. J. Proteome Res. 6, 4374–4387 (2007)
Nairn, A.V., York, W.S., et al.: Regulation of glycan structures in animal tissues: transcript profiling of glycan-related genes. J. Biol. Chem. 25, 17298–17313 (2008)
Pfaffl, M.W.: A new mathematical model for relative quantification in real-time PCR. Nucleic Acids Res. 29, 2002–2007 (2001)
Zhang, F., Sun, P., et al.: Microscale isolation and analysis of heparin from plasma using an anion-exchange spin column. Anal. Biochem. 353, 284–286 (2006)
Shaya, D., Tocili, A., et al.: Crystal structure of heparinase II from Pedobacter heparinus and its complex with a disaccharide product. J. Biol. Chem. 281, 15525–15535 (2006)
Yoshida, E., Arakawa, S., et al.: Cloning, sequencing, and expression of the gene from bacillus circulans that codes for a heparinase that degrades both heparin and heparan sulfate. Biosci. Biotech. Biochem. 66, 1873–1879 (2002)
Solakyildirim, K., Zhang, F., et al.: Ultraperformance liquid chromatography with electrospray ionization ion trap mass spectrometry for chondroitin disaccharide analysis. Anal. Biochem. 397, 24–28 (2010)
Yang, B., Weyers, A., et al.: Ultra-performace ion pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for heparin disaccharide analysis. Anal. Biochem. 415, 59–66 (2011)
Acknowledgements
The authors thank Empire State Stem Cell Fund for funding in the form of contract #C024334 and the National Institutes of Health for funding in the form of grant #3R01HL09697203.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplemental Table 1
RT-PCR primers for NCCIT characterizationa (DOC 29 kb)
Supplemental Figure 1
HP/HS disaccharide composition analysis of GAGs from NCCIT cells (DOC 919 kb)
Supplemental Figure 2
HP/HS disaccharide composition analysis of GAGs from NCCIT-RA cells (DOC 898 kb)
Supplemental Figure 3
CS/DS disaccharide composition analysis of GAGs from NCCIT cells (DOC 170 kb)
Supplemntal Figure 4
CS/DS disaccharide composition analysis of GAGs from NCCIT-RA cells (DOC 131 kb)
Rights and permissions
About this article
Cite this article
Gasimli, L., Stansfield, H.E., Nairn, A.V. et al. Structural remodeling of proteoglycans upon retinoic acid-induced differentiation of NCCIT cells. Glycoconj J 30, 497–510 (2013). https://doi.org/10.1007/s10719-012-9450-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-012-9450-x